| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 117,742 | 118,926 | 120,912 | 120,109 | | Cost of Revenue | 35,880 | 36,745 | 38,021 | 35,090 | | | Gross Profit | 81,862 | 82,181 | 82,891 | 85,019 | | | Operating Expenses | | Research Development | 8,537 | 9,017 | 8,906 | 8,577 | | Selling General and Administrative | 63,703 | 65,821 | 66,609 | 64,035 | | Non Recurring | 131 | 794 | 66 | 1,110 | | Others | 1,274 | 1,308 | 1,317 | 1,270 | | | | Total Operating Expenses | 73,645 | 76,940 | 76,898 | 74,992 | | | | Operating Income or Loss | 8,217 | 5,241 | 5,993 | 10,027 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (108) | 103 | 363 | 431 | | Earnings Before Interest And Taxes | 8,109 | 5,344 | 6,356 | 10,458 | | Interest Expense | 1,435 | 1,286 | 1,253 | 1,054 | | Income Before Tax | 6,674 | 4,058 | 5,103 | 9,404 | | Income Tax Expense | 2,522 | 1,631 | 1,786 | 12,095 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,152 | 2,427 | 3,317 | (2,691) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,152 | 2,427 | 3,317 | (2,691) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,152 | $2,427 | $3,317 | ($2,691) |
|
0.02% Nasdaq 
0.33%
Income Statement
